BiotechTube
Home/Nuevocor/Nicolas Guyon-Gellin, MD
NG

Nicolas Guyon-Gellin, MD

Chief Business Officer

Nuevocor

Therapeutic Areas

CardiovascularGenetic Cardiomyopathy

Nuevocor Pipeline

DrugIndicationPhase
NVC-001ALMNA-related Dilated CardiomyopathyPhase 1
NVC-001BUndisclosedPreclinical
NVC-002UndisclosedPreclinical

Leadership Team at Nuevocor

AG
Albert Gianchetti
Chief Executive Officer
LR
Lucie Rouch
Vice President, Clinical Operations
CL
Cheryl Lee
Vice President, Operations
CB
Christian Beck, PhD
Vice President, Corporate Development
AW
Andreas Wallnoefer, PhD, MBA
Board Chairman
MH
Mia Hu, PhD
Board Member
TA
Thierry Abribat, PhD
Board Member
KS
Khoo Shih, PhD
Board Member
ES
Elia Stupka, PhD
Board Member
AG
Amanda Gett-Chaperot, PhD, MBA
Board Member
View full Nuevocor profile